(Q63440155)

English

Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantation

scientific article published on 14 January 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195684%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195684%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

0 references

stem cell transplantation

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195684%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195684%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

11

object named as

D C Linch

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195684%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Anthony H. Goldstone

10

object named as

A H Goldstone

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195684%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

K J Thomson

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195684%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

K S Peggs

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195684%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

P Smith

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195684%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

J Cavet

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195684%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

A Hunter

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195684%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

R Pettengell

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195684%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

D Milligan

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195684%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

S Mackinnon

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195684%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

language of work or name

0 references

publication date

14 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195684%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195684%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

41

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195684%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195684%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

765-770

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18195684%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705977

7 January 2021

based on heuristic

inferred from DOI database lookup

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705977

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705977

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical course and outcome of patients with Hodgkin's disease who progress after autologous transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705977

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705977

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705977

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705977

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of blood and marrow transplantation for Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705977

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705977

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705977

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705977

7 January 2021

based on heuristic

inferred from DOI database lookup

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705977

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705977

7 January 2021

based on heuristic

inferred from DOI database lookup

'GVHD': graft-versus-host disease or graft-versus-Hodgkin's disease? An old acronym with new meaning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705977

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+ cell dose, GVHD and disease response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705977

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q63440155&oldid=2217733012"